A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2006
10/24/2006	US7125997 Differential tumor cytotoxicity compounds and compositions
10/24/2006	US7125996 Fluorescent probes for use in protein kinase inhibitor binding assay
10/24/2006	US7125995 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)
10/24/2006	US7125994 PNA monomer and precursor
10/24/2006	US7125991 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof
10/24/2006	US7125990 For treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
10/24/2006	US7125987 Process for the preparation of oxcarbazepine and related intermediates
10/24/2006	US7125986 Penicillanic acid derivative compounds and methods of making
10/24/2006	US7125985 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
10/24/2006	US7125983 L-nucleic acid derivatives and process for the synthesis thereof
10/24/2006	US7125970 Host cells; drug screening; antigrowth agents
10/24/2006	US7125947 Used to form a functionalized coating on substrate; array of nucleic acids may be covalently attached to substrate to make high density arrays to nucleic acids immobilized on substrate which may be used in high volume nucleic acid hybridization
10/24/2006	US7125911 Autonomic nerve regulating agent
10/24/2006	US7125910 Compounds and compositions for delivering active agents
10/24/2006	US7125909 Sterile parenteral nutrition compositions
10/24/2006	US7125908 Treating pain using selective antagonists of persistent sodium current
10/24/2006	US7125907 Thiolactones
10/24/2006	US7125906 Indole derivatives having anti-angiogenetic activity
10/24/2006	US7125905 Pyrrole substituted 2-indolinone protein kinase inhibitors
10/24/2006	US7125904 Cardiovascular disorders; hypotensive agents; congestive heart failure
10/24/2006	US7125903 Drugs for treatment of obsessive compulsive disorder, cognitive activators, psychosis, parkinson's disease as antagonist
10/24/2006	US7125902 Anticancer agents for, lungs, leukemia and ovarian cancer or prostate glands
10/24/2006	US7125901 Thiazole derivatives
10/24/2006	US7125900 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
10/24/2006	US7125899 Microtubule-stabilizing agents useful in the treatment of a variety of cancers
10/24/2006	US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents
10/24/2006	US7125897 Slowing or arresting progression of plaque in blood systems treatment with statins and oxidation
10/24/2006	US7125896 Thiophene carboxamide compounds as inhibitors of enzyme IKK-2
10/24/2006	US7125895 Arylalkylamine compounds as chemokine receptor antagonists for therapy and prevention of diseases such as arthritis or rheumatic diseases
10/24/2006	US7125893 Compounds useful for treatment of tumors or cancer of the stomach, colon, neck or used in angiogenesis and forming the compound with cyclization
10/24/2006	US7125892 Aryl aniline β2 adrenergic receptor agonists
10/24/2006	US7125891 Such as (1-((2,3-dihydro-2-(4-propyl-1H-imidazol-2-yl)-1H-indol-1 -yl)carbonyl)propyl)-carbamate; for inactivation of cholecystokinins
10/24/2006	US7125890 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
10/24/2006	US7125889 Administering mixtures of heterocyclic imines and anticoagulants such as heparin or aspirin, to reduce blood coagualtion in mammals
10/24/2006	US7125888 Tyrosine kinase inhibitors
10/24/2006	US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity
10/24/2006	US7125886 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group; especially for treating irritable bowel syndrome.
10/24/2006	US7125885 2-substituted-9-trifluoromethyl-11-methyl-1,2,3,4,5,11-hexahydro-6H-pyrido(3,2-b)carbazole compounds as melanin-concentrating hormone receptor modulators for treatment of G-protein coupled receptor-mediated disorders such as eating disorders, obesity, anxiety disorders and mood disorders
10/24/2006	US7125884 N-but-3-enyl norbuprenorphine and its use as analgesic
10/24/2006	US7125883 alpha v beta 3 integrin receptor modulators; treating variety of diseases including cardiovascular disorders, retinopathy, strokes, cancer, osteoporosis, tumor metastasis, high blood pressure, psoriasis, antiviral, antimycotic, antiparasitic or antibacterial therapy; 1,2-dihydropyrimidin-2-one moiety
10/24/2006	US7125882 Applying dimethylaminoethanol, tyrosine, and sulfur compound such as lipoic acid, glutathione, sulfur, resorcinol, resorcinol monoacetate, and/or sulfacetamide; skin sensitivity; side effect reduction
10/24/2006	US7125881 Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives
10/24/2006	US7125879 Prevention reproduction of virus
10/24/2006	US7125878 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
10/24/2006	US7125877 Brain disorders; psychological disorders; central nervous system disorders; antidiabetic agents; hypotensive agents
10/24/2006	US7125876 Substituted heterocyclic compounds
10/24/2006	US7125875 Cyclic protein tyrosine kinase inhibitors
10/24/2006	US7125874 Optically active 5H-pyrrolo[3,4-b] pyrazine derivative, its preparation and pharmaceutical compositions containing same
10/24/2006	US7125873 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/24/2006	US7125872 protease/thrombin inhibitors
10/24/2006	US7125871 Excitatory amino acid receptor modulators
10/24/2006	US7125870 such as N-hydroxy-2-{3-[4-(2-methyl-quinolin-4-ylmethoxy)-phenyl]-4,5-dihydro-isoxazol-5-yl}-acetamide; kits; for treatment of inflammation
10/24/2006	US7125869 Drugs for cosmetics for treatment of cardiovadcular disorders, receptors, immunology or lipid metabolism
10/24/2006	US7125868 Thienothiazine compound having anti-inflammatory and analgesic properties and method of making and using the same
10/24/2006	US7125866 Therapeutic applications of pro-apoptotic benzodiazepines
10/24/2006	US7125865 and atherosclerosis; LXR agonists which increase HDL levels; increases ABCA1 gene expression; reverse cholesterol transport; 1,2-benzisoxazole 6-yl compounds
10/24/2006	US7125864 Benzothiazepine derivatives for the treatment of hyperlipidemia
10/24/2006	US7125863 Inhibitors of dipeptidyl peptidase IV
10/24/2006	US7125862 Porphyrin-metal complexes and oxygen infusions containing the same
10/24/2006	US7125861 Produced by adding indole-3-propionic acid to water, adding chitosan to solution in pH ranging from 1.0-6.9 to form a chitosan-indole-3-propionic acid conjugate, stirring, lyophilizing to produce a stable powder; antioxidants and plant growth regulators that are inexpensive to manufacture
10/24/2006	US7125860 Cross-linked derivatives of hyaluronic acid
10/24/2006	US7125859 Preserving vitamins subject to oxidative damage by adding a sufficient amount of purified nucleic acid to vitamin such that the rate of oxidative damage of the vitamin is reduced
10/24/2006	US7125858 Hyaluronic acid in the treatment of cancer
10/24/2006	US7125857 A synthetic oligonucleotide comprising a C-5 methylcytosine recognizes and binds an allosteric site on DCTMase and suppressed its catalytic activity; anticarcinogenic and tumor agents; developmental disorders; drug resistance
10/24/2006	US7125856 Angiogenic growth factors for treatment of peripheral neuropathy
10/24/2006	US7125855 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
10/24/2006	US7125854 Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites
10/24/2006	US7125853 Bicyclic carbohydrate compounds useful in the treatment of infections caused by Flaviviridae sp., such as hepatitis C and bovine viral diarrhea viruses
10/24/2006	US7125852 Geranyl compounds
10/24/2006	US7125848 Administering conotoxins
10/24/2006	US7125842 Anti-fungal compounds and methods of use
10/24/2006	US7125840 Substituted dipeptides as growth hormone secretagogues
10/24/2006	US7125708 Composition comprising a Lactobacillus pentosus strain and uses thereof
10/24/2006	US7125687 Presenilin enhancers assays
10/24/2006	US7125573 Preventive, alleviative or remedy for hypertension
10/24/2006	US7125571 Herbal formulation
10/24/2006	US7125570 Antibacterial composition
10/24/2006	US7125568 Lipophilic drug compositions
10/24/2006	US7125567 Coating encapsulation a cores
10/24/2006	US7125565 Composition improved in the solubility or oral absorbability
10/24/2006	US7125564 Glycyrrhizin complex
10/24/2006	US7125563 Sustained release pharmaceutical preparations and methods for producing the same
10/24/2006	US7125562 Rapidly disintegrating methylcellulose tablets
10/24/2006	US7125560 Pharmaceutical composition of topiramate
10/24/2006	US7125559 Cosmetic or dermatological composition comprising a combination of an elastase inhibitor of the N-acylaminoamide family and at least one myorelaxing agent
10/24/2006	US7125557 Isolated haemocyanin polypeptide having a specific amino acid sequence recombinantly expressed in a host cell, wherein the glycosylation pattern is different from naturally occurring KLH from Megathura crenulata; may be bonded to a virus, bacteria, DNA, carbohydrate, peptide or glycoprotein
10/24/2006	US7125547 Poly(diallylamine)-based bile acid sequestrants
10/24/2006	US7125546 Polymeric micelle containing cisplatin enclosed therein and use thereof
10/24/2006	US7125542 Methods and compositions for treating conditions of the eye
10/24/2006	CA2398963C New salt form and polymorphs
10/24/2006	CA2375877C Unsaturated lipid-enriched feedstock for ruminants
10/24/2006	CA2369054C Treatment and control of ocular development
10/24/2006	CA2363690C Hsv primase inhibitors
10/24/2006	CA2336004C Use of histamine h2 agonists for the treatment of multiple sclerosis
10/24/2006	CA2332915C Compositions comprising gaba analogs and caffeine
10/24/2006	CA2330904C Fosinopril sodium tablet formulation
10/24/2006	CA2310398C 5h-pyrano[2,3-d:6,5-d']dipyrimidine derivatives having an antibacterial, antiviral and immuno-modulating activity
10/24/2006	CA2300603C New compounds of the benzylaminodiacetamide family, formulations including them, preparation process and uses
10/24/2006	CA2278541C Pharmaceutical preparations and methods for their regional administration
10/24/2006	CA2276587C Silicone core long term androgen delivery implant

1 ... 4040 4041 4042 4043 4044 4045 4046 4047 4048 4049 4050 4051 4052 4053 4054 4055 4056 4057 4058 4059 4060 ... 7860